Is a complete LIMN research report available?

No complete published report is available for Liminatus Pharma, Inc. (LIMN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Liminatus Pharma, Inc. (LIMN)

NASDAQ: LIMN · USD

$3.03

+0.14 (+4.8%)· Recorded snapshot

Market cap	4.1M
Net income (ttm)	-12.5M
EPS (ttm)	-$18.1
Shares out	1.3M
Volume	10,599
Beta	0.75

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -12.5M
EPS (ttm): -$18.1
Market cap: 4.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0001971387
Company name	Liminatus Pharma, Inc.
Country	United States
Country code	US
CUSIP number	53271X207
Earnings date	2026-11-18
Earnings time	bmo
Enterprise value	$2.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US53271X2071
Last 10-K release date	2026-03-31
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-08-21
Last stock split type	Reverse
Market cap	$4.1M
Market cap category	Nano-Cap
Next earnings date	2026-11-18
Options	No
Price	$3.03
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	LIMN
U.S. state	California
Website	https://liminatuspharma.com

Metric

Value

Amount currency

USD

CIK code

0001971387

Company name

Liminatus Pharma, Inc.

Country

United States

Country code

CUSIP number

53271X207

Earnings date

2026-11-18

Earnings time

bmo

Enterprise value

$2.5M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2018

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US53271X2071

Last 10-K release date

2026-03-31

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2026-08-21

Last stock split type

Reverse

Market cap

$4.1M

Market cap category

Nano-Cap

Next earnings date

2026-11-18

Options

Price

$3.03

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

LIMN

U.S. state

California

Website

https://liminatuspharma.com

Metric	Value
Earnings yield	-596.06%
FCF / EV yield	-172.75%
FCF yield	-102.68%
P/B ratio	10.76x
Price / tangible book value	12.91x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-596.06%

FCF / EV yield

-172.75%

FCF yield

-102.68%

P/B ratio

10.76x

Price / tangible book value

12.91x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
ROA	-95.65%
ROCE	-1,119.03%

Metric

Value

ROA

-95.65%

ROCE

-1,119.03%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-13,108
Depreciation and amortization	$2,071
EBIT	$-4.1M
EBITDA	$-4.1M
EPS	$-18.06
FCF per share	$-2.97
Financing cash flow	$5.7M
Free cash flow	$-4M
Investing cash flow	$-13,108
Net borrowing	$-1.3M
Net cash flow	$1.7M
Net income	$-12.5M
Operating income	$-4.1M

Metric

Value

Capital expenditures

$-13,108

Depreciation and amortization

$2,071

EBIT

$-4.1M

EBITDA

$-4.1M

EPS

$-18.06

FCF per share

$-2.97

Financing cash flow

$5.7M

Free cash flow

$-4M

Investing cash flow

$-13,108

Net borrowing

$-1.3M

Net cash flow

$1.7M

Net income

$-12.5M

Operating income

$-4.1M

Metric	Value
Book value per share	$0.27
Debt / equity	4.8
Interest coverage	-53.78
Long-term assets	$11,235
Long-term liabilities	$62,667
Net cash (debt)	$1.6M
Net cash / market cap	40.56%
Net debt / equity	-5.24
Piotroski F-Score	2
Property, plant and equipment	$11,235
Shareholders' equity	$300,612
Tangible book value	$300,612
Tangible book value per share	$0.27
Total assets	$3.4M
Total cash	$3M
Total debt	$1.4M
Total liabilities	$3.1M
WACC	7.24%

Metric

Value

Book value per share

$0.27

Debt / equity

4.8

Interest coverage

-53.78

Long-term assets

$11,235

Long-term liabilities

$62,667

Net cash (debt)

$1.6M

Net cash / market cap

40.56%

Net debt / equity

-5.24

Piotroski F-Score

Property, plant and equipment

$11,235

Shareholders' equity

$300,612

Tangible book value

$300,612

Tangible book value per share

$0.27

Total assets

$3.4M

Total cash

$3M

Total debt

$1.4M

Total liabilities

$3.1M

WACC

7.24%

Metric	Value
Current assets	$3.4M
Current liabilities	$3M
Current ratio	1.12
Net working capital	$-1.2M
Quick ratio	0.99
Working capital	$352,044

Metric

Value

Current assets

$3.4M

Current liabilities

$3M

Current ratio

1.12

Net working capital

$-1.2M

Quick ratio

0.99

Working capital

$352,044

Metric	Value
Buyback yield / dilution	-82.95%
Dividend yield	0%
Shareholder yield	-82.95%

Metric

Value

Buyback yield / dilution

-82.95%

Dividend yield

Shareholder yield

-82.95%

Metric	Value
150-day SMA	$6.41
1D price change	4.84%
1M price change	-27.77%
1M total return	-27.77%
1W price change	-2.88%
1W total return	-2.88%
1Y price change	-95.27%
1Y return CAGR	-95.28%
1Y total return	-95.27%
20-day SMA	$3.38
200-day SMA	$11.45
3M price change	-41.11%
3M total return	-41.11%
3Y price change	-99.42%
3Y return CAGR	-81.98%
3Y total return	-99.42%
50-day SMA	$3.77
50-day SMA vs 200-day SMA	50under200
52-week high	$141.50
52-week high date	2026-02-09
52-week low	$2.79
52-week low date	2026-10-27
5Y price change	-99.38%
5Y return CAGR	-63.82%
5Y total return	-99.38%
6M price change	-70.07%
6M total return	-70.07%
All-time high	$1,683.00
All-time high date	2025-06-25
All-time low	$2.79
All-time low date	2026-10-27
Average true range (ATR)	$0.31
Average volume	25.9K
Beta (1Y)	4.26
Beta (2Y)	2.32
Beta (5Y)	0.75
Change from 52-week high	-97.86%
Change from 52-week low	8.8%
Change from all-time high	-99.82%
Change from all-time low	8.8%
Change from open	0%
Day's gap	4.84%
Dollar volume	$32,115
High price	$3.03
Low price	$3.03
Monthly RSI	27.51
Open price	$3.03
Premarket change	9.69%
Premarket close	$2.89
Premarket price	$3.17
Premarket volume	1.7K
Previous close	$2.89
Price vs 150-day SMA	-52.74%
Price vs 20-day SMA	-10.38%
Price vs 200-day SMA	-73.53%
Price vs 50-day SMA	-19.63%
Relative volume	0.41
RSI	39.54
Sharpe ratio	-0.89
Sharpe ratio (3Y)	-0.28
Sortino ratio	-1.39
Sortino ratio (3Y)	-0.47
Volume	10.6K
Weekly RSI	37.34
YTD price change	-90.07%
YTD total return	-90.07%

Metric

Value

150-day SMA

$6.41

1D price change

4.84%

1M price change

-27.77%

1M total return

-27.77%

1W price change

-2.88%

1W total return

-2.88%

1Y price change

-95.27%

1Y return CAGR

-95.28%

1Y total return

-95.27%

20-day SMA

$3.38

200-day SMA

$11.45

3M price change

-41.11%

3M total return

-41.11%

3Y price change

-99.42%

3Y return CAGR

-81.98%

3Y total return

-99.42%

50-day SMA

$3.77

50-day SMA vs 200-day SMA

50under200

52-week high

$141.50

52-week high date

2026-02-09

52-week low

$2.79

52-week low date

2026-10-27

5Y price change

-99.38%

5Y return CAGR

-63.82%

5Y total return

-99.38%

6M price change

-70.07%

6M total return

-70.07%

All-time high

$1,683.00

All-time high date

2025-06-25

All-time low

$2.79

All-time low date

2026-10-27

Average true range (ATR)

$0.31

Average volume

25.9K

Beta (1Y)

4.26

Beta (2Y)

2.32

Beta (5Y)

0.75

Change from 52-week high

-97.86%

Change from 52-week low

8.8%

Change from all-time high

-99.82%

Change from all-time low

8.8%

Change from open

Day's gap

4.84%

Dollar volume

$32,115

High price

$3.03

Low price

$3.03

Monthly RSI

27.51

Open price

$3.03

Premarket change

9.69%

Premarket close

$2.89

Premarket price

$3.17

Premarket volume

1.7K

Previous close

$2.89

Price vs 150-day SMA

-52.74%

Price vs 20-day SMA

-10.38%

Price vs 200-day SMA

-73.53%

Price vs 50-day SMA

-19.63%

Relative volume

0.41

RSI

39.54

Sharpe ratio

-0.89

Sharpe ratio (3Y)

-0.28

Sortino ratio

-1.39

Sortino ratio (3Y)

-0.47

Volume

10.6K

Weekly RSI

37.34

YTD price change

-90.07%

YTD total return

-90.07%

Metric	Value
Float	1M
Float percentage	76.17%
Shares change (QoQ)	34.44%
Shares change (YoY)	82.95%
Shares held by insiders	12.21%
Shares held by institutions	1.41%
Shares outstanding	1.3M
Short % of float	3.87%
Short % of shares	2.95%
Short ratio	1.6 days

Metric

Value

Float

Float percentage

76.17%

Shares change (QoQ)

34.44%

Shares change (YoY)

82.95%

Shares held by insiders

12.21%

Shares held by institutions

1.41%

Shares outstanding

1.3M

Short % of float

3.87%

Short % of shares

2.95%

Short ratio

1.6 days

Liminatus Pharma, Inc. (LIMN)

Price

Financial snapshot

Fair-value bridge

Latest news · LIMN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LIMN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LIMN

Frequently asked questions